Kimberley Goldsmith

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Kimberley A. Goldsmith is a researcher and senior lecturer at the Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College, London.[1]

Notable studies[edit | edit source]

PACE trial publications include:

Main trial outcome
Other PACE trial publications

Letters[edit | edit source]

PACE trial authors' responses
  • 2019, The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al[14] (Full text)

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube

See also[edit | edit source]

Learn more[edit | edit source]

  • King's College, London

References[edit | edit source]

  1. "Kimberley Goldsmith - Research Portal, King's College, London". kclpure.kcl.ac.uk. Retrieved October 16, 2018.
  2. White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; Baber, HL; Burgess, M; Clark, LV; Cox, DL; Bavinton, J; Angus, BJ; Murphy, G; Murphy, M; O'Dowd, H; Wilks, D; McCrone, P; Chalder, T; Sharpe, M; The PACE Trial Management Group (March 5, 2011). "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial". The Lancet. 377 (9768): 823–836. doi:10.1016/S0140-6736(11)60096-2. PMID 21334061.
  3. McCrone, P; Sharpe, M; Chalder, T; Knapp, M; Johnson, AL; Goldsmith, K (August 1, 2012). "Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis". PLoS One. doi:10.1371/journal.pone.0040808. PMID 22870204.
  4. White, PD; Goldsmith, K; Johnson, AL; Chalder, T; Sharpe, M; PACE Trial Management Group (October 2013). "Recovery from chronic fatigue syndrome after treatments given in the PACE trial". Psychol Med. 43 (10): 2227-2235. doi:10.1017/S0033291713000020. PMID 3776285.
  5. Walwyn, R; Potts, L; McCrone, P; Johnson, AL; DeCesare, JC; Baber, HL; Goldsmith, KA; Sharpe, M; Chalder, T; White, PD (November 13, 2013). "A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan". Trials Journal. doi:10.1186/1745-6215-14-386.
  6. Dougall, D; Johnson, A; Goldsmith, K; Sharpe, M; Angus, B; Chalder, T; White, P (July 2014). "Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome". Journal of Psychosomatic Research. 77 (1): 20-26. doi:10.1016/j.jpsychores.2014.04.002.
  7. Chalder, T; Goldsmith, KA; White, PD; Sharpe, M; Pickles, AR (January 28, 2015). "Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial". The Lancet Psychiatry. 2 (2): 141–52. doi:10.1016/S2215-0366(14)00069-8. PMID 26359750.
  8. Sharpe, M; Goldsmith, KA; Johnson, AL; Chalder, T; Walker, J; White, PD (October 27, 2015). "Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial". The Lancet Psychiatry. 2: 1067–74. doi:10.1016/S2215-0366(15)00317-X. PMID 26521770. There was little evidence of differences in outcomes between the randomised treatment groups at long-term follow-up.
  9. Goldsmith, KA; Chalder, T; White, PD; Sharpe, M; Pickles, AR (November 17, 2015). "Longitudinal mediation in the PACE randomised clinical trial of rehabilitative treatments for chronic fatigue syndrome: modelling and design considerations". Trials Journal / Paperity.
  10. White, PD; Goldsmith, KA; Johnson, AL; Walwyn, R; Baber, HL; Chalder, T; Sharpe, M (May 17, 2011). "(correspondence) The PACE trial in chronic fatigue syndrome – Authors' reply". The Lancet. 377 (9780): 1834–1835. doi:10.1016/S0140-6736(11)60651-X.
  11. Chalder, T; Goldsmith, KA; White, PD; Sharpe, M; Pickles, AR (April 2015). "(response) Author's reply - Methods and outcome reporting in the PACE trial". The Lancet Psychiatry. 2 (4): e10–e11. doi:10.1016/S2215-0366(15)00114-5.
  12. Sharpe, M; Goldsmith, KA; Johnson, AL; Chalder, T; Walker, J; White, PD (February 2016). "(correspondence) Authors' reply - Patient reaction to the PACE trial". The Lancet Psychiatry. 3 (2): e8–e9. doi:10.1016/S2215-0366(16)00018-3.
  13. White, PD; Chalder, T; Sharpe, M; Angus, BJ; Baber, HL; Bavinton, J; Burgess, M; Clark, LV; Cox, DL; DeCesare, JC; Goldsmith, KA; Johnson, AL; McCrone, P; Murphy, G; Murphy, M; O'Dowd, H; Potts, L; Walwyn, R; Wilks, D (January 2017). "Response to the editorial by Dr Geraghty". Journal of Health Psychology. 22 (9): 1113–1117. doi:10.1177/1359105316688953.
  14. Sharpe, Michael; Goldsmith, Kim; Chalder, Trudie (March 12, 2019). "The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al". BMC Psychology. 7 (1): 15. doi:10.1186/s40359-019-0288-x. ISSN 2050-7283.